Genovis Financial Statements From 2010 to 2025
| GENO Stock | SEK 21.70 0.35 1.59% |
Check Genovis AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genovis AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genovis financial statements analysis is a perfect complement when working with Genovis AB Valuation or Volatility modules.
Genovis |
Genovis AB Company Profit Margin Analysis
Genovis AB's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Genovis AB Profit Margin | 0.34 % |
Most of Genovis AB's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genovis AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Genovis AB has a Profit Margin of 0.3446%. This is 103.07% lower than that of the Healthcare sector and 101.5% lower than that of the Biotechnology industry. The profit margin for all Sweden stocks is 127.13% lower than that of the firm.
Genovis AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genovis AB's current stock value. Our valuation model uses many indicators to compare Genovis AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genovis AB competition to find correlations between indicators driving Genovis AB's intrinsic value. More Info.Genovis AB is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genovis AB is roughly 2.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genovis AB's earnings, one of the primary drivers of an investment's value.About Genovis AB Financial Statements
Genovis AB shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Genovis AB investors may analyze each financial statement separately, they are all interrelated. The changes in Genovis AB's assets and liabilities, for example, are also reflected in the revenues and expenses on on Genovis AB's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medical device and pharmaceutical industries. Genovis AB was founded in 1999 and is based in Lund, Sweden. Genovis AB operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 20 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Genovis Stock Analysis
When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.